Emerging Treatment Strategies for COVID-19

Tuesday, April 7, 2020, 12:00 AM - Wednesday, April 7, 2021, 12:00 AM

Internet Enduring Material sponsored by the Stanford University School of Medicine. Presented by the Department of Radiology at the Stanford University School of Medicine. 

This video presentation provided an overview of ongoing drug therapies currently in clinical trials. The session focused on the various drugs, and combination of drugs, their efficacy and side effects. Provided in depth discussions of drug treatment options. 6 ongoing clinical trials worldwide for Remdesivir. Adaptive trial at Stanford and other sites around the country. Stanford’s phase three trial is ongoing. Reviewed the study design and to date results.

  Release Date: April 7, 2020
  Expiration Date: April 7, 2021
  Estimated Time to Complete: 29 minutes
  CME Credits Offered: 0.50
  Registration Fee: FREE

*Originally recorded 03/27/2020.

AMA PRA Category 1 Credits™ (0.50 hours), Non-Physician Participation Credit (0.50 hours)

1. Review clinical study data in order to stay abreast of possible treatment options for COVID-19.

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

American Medical Association (AMA)
Stanford Medicine designates this Enduring Material for a maximum of 0.50 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008. 

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: http://lane.stanford.edu/portals/cultural.html

Reference/Bibliography List
COVID-19 CME Resources https://med.stanford.edu/cme/COVID19.html

The Stanford University School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education.   There are no relevant financial relationships with ACCME-defined commercial interests for anyone who was in control of the content of this activity.